文献速递神经核医学肿瘤 PET/CT

胶质瘤综合治疗后脑[11C]甲硫氨酸PET/CT持续非肿瘤性高氨基酸摄取一例

Persistent Nontumoral High-Amino-Acid Uptake on Brain [11C]Methionine PET/CT in a Patient After Combined Glioma Treatment.
PubMed 文献 · Clin Nucl Med · 2021-01-01

一例44岁男性左颞叶低级别胶质瘤综合治疗后出现每日多次癫痫发作,MRI示左额叶弥漫性皮层肿胀伴明显脑回强化,[11C]甲硫氨酸PET显示左大脑半球皮层带 strictly 限局性摄取增高并持续3个月。活检未见肿瘤复发,随访2年MRI脑回强化持续存在,PET示左额顶叶皮层高摄取逐渐加重。

要点

  • 胶质瘤治疗后[11C]甲硫氨酸PET皮层带高摄取可持续存在且非肿瘤复发。
  • 影像学异常包括弥漫性皮层肿胀、脑回强化及氨基酸摄取增高,需与复发鉴别。
  • 活检是排除肿瘤复发的关键手段,随访中PET高摄取可呈逐渐加重趋势。

核心结论

  • 胶质瘤综合治疗后[11C]甲硫氨酸PET/CT可显示严格限于皮层带的持续性高摄取,活检证实为非肿瘤性改变。

研究设计与样本

  • 单例病例报告:44岁男性左颞叶低级别胶质瘤综合治疗后,行MRI与[11C]甲硫氨酸PET/CT检查及活检,随访2年。

主要发现

  • MRI示左额叶弥漫性皮层肿胀伴明显脑回强化,PET示左大脑半球皮层带摄取增高并持续3个月。
  • 活检未发现肿瘤复发证据。
  • 随访2年MRI左半球弥漫性脑回强化持续存在,PET示左额叶和顶叶皮层高[11C]甲硫氨酸摄取逐渐加重。

临床怎么用

  • 胶质瘤治疗后出现皮层带局限性[11C]甲硫氨酸高摄取时,不应仅凭PET判断肿瘤复发,需结合活检及随访。

局限性

  • 单例病例报告,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 44-year-old man after combined left temporal low-grade glioma treatment presented with daily multiple series of seizures. MRI demonstrated diffuse cortical swelling in the left frontal lobe with intensive gyral enhancement. PET with [11C]methionine (PET-MET) revealed increased radiotracer uptake strictly confined to the cortical ribbon of the left cerebral hemisphere, which persisted for 3 months. Tumor recurrence was suggested, and biopsy was performed. No evidence of recurrent tumor was found. During a 2-year follow-up, a diffuse gyral enhancement in the left hemisphere has persisted on MRI; PET has shown high [11C]methionine uptake in the left frontal and parietal cortex with gradual positive dynamics.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Skvortsova TY, Savintceva ZI, Zhavoronkova AS, et al. Persistent Nontumoral High-Amino-Acid Uptake on Brain [11C]Methionine PET/CT in a Patient After Combined Glioma Treatment. Clin Nucl Med. 2021. PMID: 33661209. doi:10.1097/RLU.0000000000003559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。